MMM — Medicare/Medicaid
H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025: payment rates H.R. 1317 (2025-2026), I CAN Act: provision of service under Medicare Medicare sequester, PAYGO Medicare Advantage Upcoding Medicare for All/Public Option Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Medicare Physician Fee Schedule Rule Budget neutrality Medicare Economic Index: Medicare inflationary increase Medicaid Bundled payments H.R. 5454/S. 2879 Medicare Advantage Prompt Pay Act WISeR Model Medicare Administrative Contractor (MAC) Local Coverage Determinations (LCD) Practice Expense (PE) Opioid sparing Labor, Health and Human Services (LHHS) Appropriation S.586 - NOPAIN Act: Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act
Lobbyists: MANUEL BONILLA; ms NORA BAUMEISTER MATUS; MATTHEW T POPOVICH; CAVAN JONES
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
Graduate Medical Education Certified Anesthesiologist Assistants Anesthesia workforce shortages HR 3890, Resident Physician Shortage Reduction Act of 2025: residency positions S.709, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas HR 2028; Resident Education Deferred Interest Act (REDI Act): Student loan relief Anesthesia Research Funding Scope of Practice Merit-based Incentive Payment System, MIPS, MIPS Value Pathway Quality Payment Program, QPP Alternative Payment Model, APM QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Conditions of Participation - Anesthesia services, opt-outs, supervision CMS: Federal Independent Dispute Resolution (IDR) Process, Batching H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227/S.475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options Pain Medicine Prescription Drug Abuse CDC Opioid Prescribing Guideline H.R. 3595, Safe Prescribing Through Reporting Act of 2025: disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs Drug shortages DEA Scheduling Propofol FDA Safe Use Initiative FDA Operating Room Fires FDA Opioids FDA Network of Experts FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) USP - US Pharmacopeia Compounding NIH Interagency Pain Research Coordinating Committee NIH: Funding, Indirect Costs, Indirect Grants, Overhead Agency for Healthcare Research and Quality (AHRQ) funding Long COVID research 21st Century Cures Initiative Out of Network/Out of Network Payment Network Adequacy Pre-authorization; prior authorization Insurance reform, shared savings, insurer accountability Affordable Care Act reform efforts Provider Nondiscrimination Change Healthcare, Change Healthcare data breach HR 292 Lorna Breen Reauthorization H.R. 3178, SAVE Healthcare Workers Act: To protect hospital personnel from violence, and for other purposes Maternal Mortality/Maternal Care Deserts Blood management 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care S. 2759/H.R. 5283, the Healthcare Workforce Resilience Act, Exemption for Physicians from New H-1B Visa Policy and $100,000 Fee Medical journal fees No Surprises Act (NSA) - H.R.4710 / S. 2420, the No Surprises Enforcement Act H.R. 3164, the Ensuring Community Access to Pharmacist Services Act Advance Premium Tax Credits (APTCs) Federal regulation of commercial health insurance companies One Big Beautiful Bill (OBBB) Commercial payer/payment
Lobbyists: MANUEL BONILLA; ms NORA BAUMEISTER MATUS; MATTHEW T POPOVICH; CAVAN JONES
Government entities lobbied: Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Drug Enforcement Administration (DEA); Executive Office of the President (EOP); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Occupational Safety & Health Administration (OSHA); Office of Management & Budget (OMB); SENATE; Veterans Affairs, Dept of (VA); White House Office
VET — Veterans
Veterans Affairs Advance Practice Registered Nurses HR 3944, Mil Con VA: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act of 2026 VA Physician/Provider Hiring Federal Supremacy Initiative (National Standards of Practice): reduction in patient safety standard Defense Health Agency (DHA): Physician-led care and scope of practice VHA Directive 1123, National Anesthesia Program/Safe Anesthesia Standards in the VA Defense Health Agency anesthesia policy VA Sterile Processing
Lobbyists: MANUEL BONILLA; ms NORA BAUMEISTER MATUS; MATTHEW T POPOVICH; CAVAN JONES
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)